Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist was written by Schnute, Mark E.;Wennerstal, Mattias;Alley, Jennifer;Bengtsson, Martin;Blinn, James R.;Bolten, Charles W.;Braden, Timothy;Bonn, Tomas;Carlsson, Bo;Caspers, Nicole;Chen, Ming;Choi, Chulho;Collis, Leon P.;Crouse, Kimberly;Farnegardh, Mathias;Fennell, Kimberly F.;Fish, Susan;Flick, Andrew C.;Goos-Nilsson, Annika;Gullberg, Hjalmar;Harris, Peter K.;Heasley, Steven E.;Hegen, Martin;Hromockyj, Alexander E.;Hu, Xiao;Husman, Bolette;Janosik, Tomasz;Jones, Peter;Kaila, Neelu;Kallin, Elisabet;Kauppi, Bjorn;Kiefer, James R.;Knafels, John;Koehler, Konrad;Kruger, Lars;Kurumbail, Ravi G.;Kyne, Robert E.;Li, Wei;Lofstedt, Joakim;Long, Scott A.;Menard, Carol A.;Mente, Scot;Messing, Dean;Meyers, Marvin J.;Napierata, Lee;Noteberg, Daniel;Nuhant, Philippe;Pelc, Matthew J.;Prinsen, Michael J.;Rhonnstad, Patrik;Backstrom-Rydin, Eva;Sandberg, Johnny;Sandstrom, Maria;Shah, Falgun;Sjoberg, Maria;Sundell, Aron;Taylor, Alexandria P.;Thorarensen, Atli;Trujillo, John I.;Trzupek, John D.;Unwalla, Ray;Vajdos, Felix F.;Weinberg, Robin A.;Wood, David C.;Xing, Li;Zamaratski, Edouard;Zapf, Christoph W.;Zhao, Yajuan;Wilhelmsson, Anna;Berstein, Gabriel. And the article was included in Journal of Medicinal Chemistry in 2018.Product Details of 1711-11-1 This article mentions the following:
The nuclear hormone receptor retinoic acid receptor-related orphan C2 (RORC2, also known as RORγt) is a promising target for the treatment of autoimmune diseases. A small mol., inverse agonist of the receptor is anticipated to reduce production of IL-17, a key proinflammatory cytokine. Through a high-throughput screening approach, authors identified a mol. displaying promising binding affinity for RORC2, inhibition of IL-17 production in Th17 cells, and selectivity against the related RORA and RORB receptor isoforms. Lead optimization to improve the potency and metabolic stability of this hit focused on two key design strategies, namely, iterative optimization driven by increasing lipophilic efficiency and structure-guided conformational restriction to achieve optimal ground state energetics and maximize receptor residence time. This approach successfully identified 3-cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide as a potent and selective RORC2 inverse agonist, demonstrating good metabolic stability, oral bioavailability, and the ability to reduce IL-17 levels and skin inflammation in a preclin. in vivo animal model upon oral administration. In the experiment, the researchers used many compounds, for example, 3-Cyanobenzoyl chloride (cas: 1711-11-1Product Details of 1711-11-1).
3-Cyanobenzoyl chloride (cas: 1711-11-1) belongs to organic chlorides. Organic chlorides can be used in production of: PVC, pesticides, chloromethane, teflon, insulators. Alkyl chlorides are versatile building blocks in organic chemistry. While alkyl bromides and iodides are more reactive, alkyl chlorides tend to be less expensive and more readily available.Product Details of 1711-11-1
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics